This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2006 Oct;13(5):147-59.

doi: 10.3747/co.v13i5.130.

Recent advances in adjuvant systemic treatment for breast cancer: all systems go!

P N Fishman¹, S Verma

Affiliations

PMID: 22792012
PMCID: PMC3394598
DOI: 10.3747/co.v13i5.130

Recent advances in adjuvant systemic treatment for breast cancer: all systems go!

P N Fishman et al. Curr Oncol. 2006 Oct.

. 2006 Oct;13(5):147-59.

doi: 10.3747/co.v13i5.130.

Authors

P N Fishman¹, S Verma

Affiliation

¹ Department of Medical Oncology, Toronto Regional Cancer Centre, University of Toronto, Toronto, Ontario.

PMID: 22792012
PMCID: PMC3394598
DOI: 10.3747/co.v13i5.130

No abstract available

Keywords: Breast cancer; adjuvant; treatment.

PubMed Disclaimer

Similar articles

Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Gonzalez-Angulo AM, et al. Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer.
López-Tarruella S, Martín M. López-Tarruella S, et al. Breast Cancer Res. 2009;11(2):204. doi: 10.1186/bcr2226. Epub 2009 Mar 19. Breast Cancer Res. 2009. PMID: 19344489 Free PMC article. Review.
The new millennium for adjuvant therapy in breast cancer.
Sledge GW Jr. Sledge GW Jr. Oncology (Williston Park). 2008 May;22(6):598-602; discussion 602-3, 606, 608. Oncology (Williston Park). 2008. PMID: 18561550 Review.
Recent advances in the management of primary breast cancers.
Lu YS, Kuo SH, Huang CS. Lu YS, et al. J Formos Med Assoc. 2004 Aug;103(8):579-98. J Formos Med Assoc. 2004. PMID: 15340657 Review.
Adjuvant chemotherapy for breast cancer.
Green MC, Hortobagyi GN. Green MC, et al. Langenbecks Arch Surg. 2002 Jul;387(3-4):109-116. doi: 10.1007/s00423-002-0288-8. Langenbecks Arch Surg. 2002. PMID: 12269263 Review.

See all similar articles

References

1. Canadian Cancer Society and the National Cancer Institute of Canada. Canadian Cancer Statistics 2006. Toronto: Canadian Cancer Society; 2006.
1. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–92. - PubMed
1. Osborne CK, Yochmowitz MG, Knight WA, 3rd, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980;46:2884–8. - PubMed
1. Early Breast Cancer Trialists’ Collaborative Group (ebctcg) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717. - PubMed
1. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005;97:1652–62. - PubMed

LinkOut - more resources

Full Text Sources